OCGNOcugen, Inc.
Is it growing?
Neither accelerating nor breaking down: operating margin widening (+2623.2 points), but revenue shrinking (−4% year on year).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Trailing-twelve-month operating margin, 1382.7% now against -1240.5% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is OCGN growing?
Ocugen, Inc.'s revenue has grown 26% a year over three years.
Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue
- Years of annual history on file
- 12
Years of annual history on file · FY2014 to FY2025, as filed
Details›
- Revenue FY2021
- $0
- Revenue FY2022
- $2.5M
- Revenue FY2023
- $6.0M
- Revenue FY2024
- $4.1M
- Revenue FY2025
- $4.4M
Annual income statements as filed with the SEC.